Please ensure Javascript is enabled for purposes of website accessibility

IQVIA Holdings Ends 2017 Strong, Shares Bullish Guidance

By Brian Feroldi - Updated Feb 20, 2018 at 8:15AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The leading provider of services and data for the life sciences industry posted double-digit gains in revenue and profits.

IQVIA Holdings (IQV 1.07%), which was formerly known as Quintiles IMS Holdings, reported its fourth-quarter and full-year results on Wednesday, Feb. 14. Revenue and profits continued their upward climb as the company's push into technology helped it win more than its fair share of new business. 

Let's put IQVIA's results under the microscope to learn more about why it performed so well during the period.

Woman in lab coat looking through a microscope

Image source: Getty Images.

IQVIA Holdings Q4: The raw numbers

Metric

Q4 2017

Q4 2016

Year-Over-Year Change

Revenue

$2.16 billion

$1.95 billion 

10.7%

Adjusted earnings before interest, taxes, depreciation, and amortization

$582 million

$541 million

4.7%

Adjusted net income

$300 million

$266 million

13%

Adjusted earnings per share

$1.40

$1.09

28%

Data source: Quintiles IMS Holdings.

What happened with IQVIA this quarter?

  • Revenue of $2.16 billion came in at the high end of management's forecast
  • Commercial Solutions revenue grew 10.6% to $1.03 billion.
  • Research & Development Solutions revenue grew 6.6% to $947 million.
  • Integrated Engagement Services revenue fell 3.3% to $187 million.
  • Adjusted EBITDA of $582 million came in toward the top of management's guidance range.
  • Adjusted EPS of $1.40 came in $0.03 above the high end of guidance.
  • The company's book-to-bill ratio over the last 12 months ticked up to 1.24, which hints that demand for the company's services remains robust.
  • The backlog at the end of 2017 grew 2% quarter over quarter to $10.54 billion.
  • Stock buybacks during the quarter totaled $369 million. After the end of the quarter, IQVIA's board increased its repurchase authorization by $1.5 billion. In total, the company now has the green light to buy back up to $1.7 billion more in common stock.

Zooming out to the full year, here's a review of IQVIA's headline numbers from 2017:

  • Revenue grew 4.3% to $8.06 billion.
  • Adjusted EBITDA increased 65% to $2.05 billion.
  • Adjusted net income grew 290% to $1.04 billion.
  • Adjusted EPS increased 328% to $4.67.

It is important for investors to remember that these eye-popping profit growth numbers are still being heavily impacted by the merger of Quintiles and IMS Health in 2016. 

What management had to say

Here's what IQVIA's CEO Ari Bousbib had to say about the quarter: "We closed out the year with fourth-quarter financial results on or above our targets, driven by strong operational execution. We are pleased with our progress during our first full year as a merged company and look forward to delivering another solid performance in 2018."

On the call with investors, Bousbib also stated that the company's focus on technology is helping it to gain traction in its core research and development markets. Specifically, he stated that the company had over $5 billion of gross bookings awarded in 2017, which is a company record.

Looking forward

On the investor call, CFO Mike McDonnell spent a great deal of time explaining that the company has adopted a new accounting standard called ASC 606 as of Jan. 1, 2018. This change will impact the company's revenue recognition policy and hence will make year-over-year comparisons difficult. To account for this change, McDonnell provided investors with guidance for 2018 that assumes that ASC 606 had been adopted in 2017 as well so investors can make an apples-to-apples comparison.

Knowing that, here is the guidance that management is offering for the full year 2018:

Metric 2018 Forecast  2017 Actual (ASC 606) Growth
Revenue $10 billion to $10.2 billion $9.70 billion 3% to 5%
Adjusted EBITDA $2.15 billion to $2.22 billion $2.01 billion 7% to 10%
Adjusted EPS $5.20 to $5.45 $4.55 14% to 20%

Data source: IQVIA Holdings. 

And here's what management is projecting will happen in the first quarter of 2018:

Metric Q1 2018 Guidance Range 
Revenue $2.42 billion to $2.47 billion
Adjusted EBITDA $520 million to $540 million
Adjusted EPS $1.23 to $1.30

Data source: IQVIA Holdings. 

McDonnell ended his prepared remarks on the investors' call by summarizing the company's key accomplishments in 2017: "We successfully merged two large organizations, repositioned the company in the market and rebranded the company as IQVIA, and of course, we were honored to be included in the S&P 500. We look forward to delivering another year of strong financial performance in 2018."

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

IQVIA Holdings Stock Quote
IQVIA Holdings
IQV
$213.80 (1.07%) $2.26

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.